These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 1727475)

  • 41. Soluble CD4 induces the binding of human immunodeficiency virus type 1 to cells via the V3 loop of glycoprotein 120 and specific sites in glycoprotein 41.
    Demaria S; Bushkin Y
    AIDS Res Hum Retroviruses; 1996 Mar; 12(4):281-90. PubMed ID: 8906988
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of the noncovalent complex of human immunodeficiency virus glycoprotein 120 with its cellular receptor CD4 by matrix-assisted laser desorption/ionization mass spectrometry.
    Borchers C; Tomer KB
    Biochemistry; 1999 Sep; 38(36):11734-40. PubMed ID: 10512629
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor.
    Brighty DW; Rosenberg M; Chen IS; Ivey-Hoyle M
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7802-5. PubMed ID: 1909031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DC-SIGN increases the affinity of HIV-1 envelope glycoprotein interaction with CD4.
    Hijazi K; Wang Y; Scala C; Jeffs S; Longstaff C; Stieh D; Haggarty B; Vanham G; Schols D; Balzarini J; Jones IM; Hoxie J; Shattock R; Kelly CG
    PLoS One; 2011; 6(12):e28307. PubMed ID: 22163292
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gp120 stability on HIV-1 virions and Gag-Env pseudovirions is enhanced by an uncleaved Gag core.
    Hammonds J; Chen X; Ding L; Fouts T; De Vico A; zur Megede J; Barnett S; Spearman P
    Virology; 2003 Sep; 314(2):636-49. PubMed ID: 14554091
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Characterization of CD4-gp120 activation intermediates during human immunodeficiency virus type 1 syncytium formation.
    Hart TK; Truneh A; Bugelski PJ
    AIDS Res Hum Retroviruses; 1996 Sep; 12(14):1305-13. PubMed ID: 8891109
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
    Keller PW; Morrison O; Vassell R; Weiss CD
    J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cryo-EM structure of a CD4-bound open HIV-1 envelope trimer reveals structural rearrangements of the gp120 V1V2 loop.
    Wang H; Cohen AA; Galimidi RP; Gristick HB; Jensen GJ; Bjorkman PJ
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):E7151-E7158. PubMed ID: 27799557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of a gp120 binding assay to dissect the requirements and kinetics of human immunodeficiency virus fusion events.
    Doranz BJ; Baik SS; Doms RW
    J Virol; 1999 Dec; 73(12):10346-58. PubMed ID: 10559353
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phenotypic Correlates of HIV-1 Macrophage Tropism.
    Arrildt KT; LaBranche CC; Joseph SB; Dukhovlinova EN; Graham WD; Ping LH; Schnell G; Sturdevant CB; Kincer LP; Mallewa M; Heyderman RS; Rie AV; Cohen MS; Spudich S; Price RW; Montefiori DC; Swanstrom R
    J Virol; 2015 Nov; 89(22):11294-311. PubMed ID: 26339058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Conjugation of soluble CD4 without loss of biological activity via a novel carbohydrate-directed cross-linking reagent.
    Chamow SM; Kogan TP; Peers DH; Hastings RC; Byrn RA; Ashkenazi A
    J Biol Chem; 1992 Aug; 267(22):15916-22. PubMed ID: 1639820
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Binding to CD4 of synthetic peptides patterned on the principal neutralizing domain of the HIV-1 envelope protein.
    Autiero M; Abrescia P; Dettin M; Di Bello C; Guardiola J
    Virology; 1991 Dec; 185(2):820-8. PubMed ID: 1720590
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The role of CD4 in HIV binding and entry.
    Sattentau QJ; Moore JP
    Philos Trans R Soc Lond B Biol Sci; 1993 Oct; 342(1299):59-66. PubMed ID: 7904348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The potential molecular targets of marine sulfated polymannuroguluronate interfering with HIV-1 entry. Interaction between SPMG and HIV-1 rgp120 and CD4 molecule.
    Meiyu G; Fuchuan L; Xianliang X; Jing L; Zuowei Y; Huashi G
    Antiviral Res; 2003 Jul; 59(2):127-35. PubMed ID: 12895696
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Conformational rearrangement within the soluble domains of the CD4 receptor is ligand-specific.
    Ashish ; Juncadella IJ; Garg R; Boone CD; Anguita J; Krueger JK
    J Biol Chem; 2008 Feb; 283(5):2761-72. PubMed ID: 18045872
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cyanovirin-N, a potent human immunodeficiency virus-inactivating protein, blocks both CD4-dependent and CD4-independent binding of soluble gp120 (sgp120) to target cells, inhibits sCD4-induced binding of sgp120 to cell-associated CXCR4, and dissociates bound sgp120 from target cells.
    Mori T; Boyd MR
    Antimicrob Agents Chemother; 2001 Mar; 45(3):664-72. PubMed ID: 11181340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.
    Esser MT; Mori T; Mondor I; Sattentau QJ; Dey B; Berger EA; Boyd MR; Lifson JD
    J Virol; 1999 May; 73(5):4360-71. PubMed ID: 10196334
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calcium ions are required for cell fusion mediated by the CD4-human immunodeficiency virus type 1 envelope glycoprotein interaction.
    Dimitrov DS; Broder CC; Berger EA; Blumenthal R
    J Virol; 1993 Mar; 67(3):1647-52. PubMed ID: 8437234
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early intermediates in HIV-1 envelope glycoprotein-mediated fusion triggered by CD4 and co-receptor complexes.
    Dimitrov AS; Xiao X; Dimitrov DS; Blumenthal R
    J Biol Chem; 2001 Aug; 276(32):30335-41. PubMed ID: 11397808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.